scholarly journals Measure of Scientific Impact: How Altmetrics Can Innovate the Approach in a Multidimensional Model

2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Valeria Scotti ◽  
Annalisa De Silvestri ◽  
Luigia Scudeller ◽  
Chiara Rebuffi ◽  
Funda Topuz ◽  
...  

Crisis ◽  
2018 ◽  
Vol 39 (6) ◽  
pp. 416-427 ◽  
Author(s):  
Antoon A. Leenaars ◽  
Gudrun Dieserud ◽  
Susanne Wenckstern ◽  
Kari Dyregrov ◽  
David Lester ◽  
...  

Abstract. Background: Theory is the foundation of science; this is true in suicidology. Over decades of studies of suicide notes, Leenaars developed a multidimensional model of suicide, with international (crosscultural) studies and independent verification. Aim: To corroborate Leenaars's theory with a psychological autopsy (PA) study, examining age and sex of the decedent, and survivor's relationship to deceased. Method: A PA study in Norway, with 120 survivors/informants was undertaken. Leenaars' theoretical–conceptual (protocol) analysis was undertaken of the survivors' narratives and in-depth interviews combined. Results: Substantial interjudge reliability was noted (κ = .632). Overall, there was considerable confirmatory evidence of Leenaars's intrapsychic and interpersonal factors in suicide survivors' narratives. Differences were found in the age of the decedent, but not in sex, nor in the survivor's closeness of the relationship. Older deceased people were perceived to exhibit more heightened unbearable intrapsychic pain, associated with the suicide. Conclusion: Leenaars's theory has corroborative verification, through the decedents' suicide notes and the survivors' narratives. However, the multidimensional model needs further testing to develop a better evidence-based way of understanding suicide.



2019 ◽  
Vol 43 (4) ◽  
pp. 383-396 ◽  
Author(s):  
Faith E. Gifford ◽  
Michael D. Reisig


2020 ◽  
Vol 25 (1) ◽  
pp. 46-67 ◽  
Author(s):  
Sonja Scherer ◽  
Dieter Zapf ◽  
Lena A. Beitler ◽  
Kai Trumpold


2018 ◽  
Vol 11 (4) ◽  
pp. 198 ◽  
Author(s):  
S. Akimov ◽  
Pavel Vedeneev ◽  
Alexandr Mikhailovich Pishchukhin


2015 ◽  
Vol 3 (1) ◽  
Author(s):  
G.S. Sharov ◽  
E.G. Vorontsova


2020 ◽  
Vol 15 (2) ◽  
pp. 132-142
Author(s):  
Priyanka Kriplani ◽  
Kumar Guarve

Background: Arnica montana, containing helenalin as its principal active constituent, is the most widely used plant to treat various ailments. Recent studies indicate that Arnica and helenalin provide significant health benefits, including anti-inflammatory, neuroprotective, antioxidant, cholesterol-lowering, immunomodulatory, and most important, anti-cancer properties. Objective: The objective of the present study is to overview the recent patents of Arnica and its principal constituent helenalin, including new methods of isolation, and their use in the prevention of cancer and other ailments. Methods: Current prose and patents emphasizing the anti-cancer potential of helenalin and Arnica, incorporated as anti-inflammary agents in anti-cancer preparations, have been identified and reviewed with particular emphasis on their scientific impact and novelty. Results: Helenalin has shown its anti-cancer potential to treat multiple types of tumors, both in vitro and in vivo. It has also portrayed synergistic effects when given in combination with other anti- cancer drugs or natural compounds. New purification/isolation techniques are also developing with novel helenalin formulations and its synthetic derivatives have been developed to increase its solubility and bioavailability. Conclusion: The promising anti-cancer potential of helenalin in various preclinical studies may open new avenues for therapeutic interventions in different tumors. Thus clinical trials validating its tumor suppressing and chemopreventive activities, particularly in conjunction with standard therapies, are immediately required.



Sign in / Sign up

Export Citation Format

Share Document